Clinical Trial Update: NBMI Treatment in Patients With Mercury Toxicity [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for NBMI treatment in mercury poisoning spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mercury Poisoning

Drugs mentioned

• NBMI

Snippet

Sponsor: EmeraMed | Conditions: Mercury Poisoning | Phase 2, Phase 3 | Status: UNKNOWN